Skip to main content
. 2023 Jan 6;34(1):50–57. doi: 10.52312/jdrs.2023.876

Table 3. Outcome measurement.

  Baseline Post-injection 2 weeks 4 weeks 12 weeks 24 weeks
Measure follow-up Mean±SD Mean±SD Mean±SD Mean±SD Mean±SD
Visual Analog Scale          
ArtiAid®-Mini 5.6±0.5 2.6±1.6a 2.0±1.2a 0.9±0.8a, b, c 0.5±0.8a, b, c
Ostenil®-Mini 5.9±1.1 1.9±1.1a 1.9±1.1a 1.1±1.0a, b, c 0.4±0.7a, b, c, d
p 0.954 0.287 0.784 0.594 0.700
Flexion (degrees)          
ArtiAid®-Mini 12.8±2.1 14.3±1.2a 14.8±0.7a 14.9±0.4a 15.0±0.0a
Ostenil®-Mini 11.6±1.1 14.3±1.0a 14.1±1.3a 14.9±0.4a 15.0±0.0a
p 0.213 >0.999 0.267 >0.999 >0.999
Extension (degrees)          
ArtiAid®-Mini 47.5±3.8 51.9±5.3a 52.8±4.5a 53.8±4.4a 58.6±6.5a, b, c, d
Ostenil®-Mini 44.4±8.2 51.1±6.1a 49.6±8.4a 52.5±5.4a 55.0±6.6a
p 0.469 0.808 0.371 0.619 0.285
Adduction (degrees)          
ArtiAid®-Mini 52.5±2.7 56.5±3.1a 59.5±6.1a 58.9±3.8a 62.8±4.8a,b
Ostenil®-Mini 53.3±4.2 56.1±4.9a 57.6±4.4a 60.0±3.8a 61.6±2.3a,b
p 0.864 0.951 0.526 0.562 0.499
Pinch (kg)          
ArtiAid®-Mini 3.9±0.5 4.8±0.9a 4.7±0.4a 4.9±0.7a 5.3±0.6a, bc
Ostenil®-Mini 5.0±2.2 4.9±1.1a 5.7±2.0a 5.9±2.5a 7.1±2.7a, b, c
p 0.314 0.907 0.788 0.958 0.290
Grip (kg)          
ArtiAid®-Mini 17.9±3.0 19.7±2.4a 19.8±2.4a 21.1±1.8a 22.9±3.7a, b, c
Ostenil®-Mini 21.7±6.2 24.4±6.6a 24.8±6.5a 26.5±7.9a 28.4±10.3a
p 0.494 0.402 0.074 0.099 0.195
Satisfaction          
ArtiAid®-Mini   4.0±0.0 4.0±0.0 4.0±0.0a 4.0±0.0
Ostenil®-Mini   3.9±0.4 4.0±0.0 4.0±0.0 4.1±0.4
p   0.351 NaN NaN 0.351
NaN: Not a number; a,b,c,d: Different superscript numbers indicate a statistically significant difference across time points by post-hoc test.